Cancer Progress

We look forward to seeing you at the 26th Annual Cancer Progress Conference on March17-18 at the Grand Hyatt
New York in New York City!


Cancer Progress

Since 1985, Cancer Progress is the only oncology conference that invites a discussion of scientific progress within the context of development, regulatory, clinical, commercial and investment perspectives in two days of interactive dialogue. Pivotal topics, frank discussions, vigorous debate, lively audience participation and generous networking throughout the meeting during breaks, luncheons, reception and dinner combine to make this a highly impactful conference.

Our 26th Annual Meeting on March 17-18, 2015 will  provide an unsurpassed learning experience for participants in quality of information, coverage of issues, and value of professional contacts. The quality of the speaking faculty is a major contributor to the popularity and value of this conference. Confirmed speakers as of July 4, 2014 are:

  • Peter C. Adamson, MD, The Children’s Hospital of Philadelphia
  • Rafael Amado, MD, GlaxoSmithKline
  • Peter Bach, MD, Memorial Sloan-Kettering Cancer Center
  • Jeff Bockman, PhD, Defined Health
  • Renier J. Brentjens, MD, PhD, Memorial Sloan Kettering Cancer Center
  • Meredith K. Chuk, MD, FDA
  • Robert Cohen, MD, Calico Life Sciences
  • Heather Cooper-Ortner, Dr. Susan Love Research Foundation
  • Lou DeGennaro, PhD, Leukemia & Lymphoma Society
  • Kathleen A. Denis, PhD, The Rockefeller University
  • Kapil Dhingra, MD, KAPital Consulting LLC
  • James H. Doroshow, MD, National Cancer Institute
  • Thomas J. Farrell, Bellicum Pharmaceuticals
  • Stanley R. Frankel, MD, Amgen
  • Richard Brian Gaynor, MD, Eli Lilly and Company
  • William Grossman, MD, PhD, AbbVie
  • Axel Hoos, MD, PhD, GlaxoSmithKline
  • Clifford A. Hudis, MD, Memorial Sloan Kettering Cancer Center, 2013-2014 President, ASCO
  • Amy Krie, MD, Avera Cancer Institute
  • Christoph Lengauer, MD, PhD, Blueprint Medicines
  • Ross Levine, MD, Memorial Sloan Kettering Cancer Center
  • Hy Levitsky, MD, Roche Pharmaceuticals
  • Brian Leyland-Jones, MD, Avera Cancer Institute
  • Patricia LoRusso, D.O., Smilow Cancer Center, Yale University
  • Susan Love, MD, Dr. Susan Love Research Foundation
  • Franziska Michor, PhD, Harvard School of Public Health
  • Ronnie Morris, MD, Champions Oncology
  • Lee Newcomer, MD, MHA, United Healthcare
  • Larry Norton, MD, Memorial Sloan Kettering Cancer Center
  • Mike Rice, MS, MBA, Defined Health
  • Carlos Rodriguez-Galindo, MD, Harvard Medical School
  • Noemi Rosa, MD, PhD, GlaxoSmithKline
  • Neal Rosen, MD, PhD, Memorial Sloan Kettering Cancer Center
  • Eric Rowinsky, MD, Stemline Therapeutics
  • Rob Ruijtenbeek, PamGene BV
  • Prof. Dolores J. Schendel, PhD, Medigene
  • Jeffrey Settleman, PhD, Genetech
  • Angela Shen, MD, MBA, Novartis Pharmaceuticals Corp.
  • Ellen V. Sigal, PhD, Friends of Cancer Research
  • Mark J. Simon, Torreya Partners LLC
  • Eric Slosberg, PhD, Novartis Oncology
  • John J. Sninsky, PhD, Quest Diagnostics
  • David Solit, MD, Memorial Sloan Kettering Cancer Center
  • Chris H. Takimoto, MD, PhD, Janssen Research & Development
  • Marc Theoret, MD, FDA
  • Jedd Wolchok, MD, PhD, Memorial Sloan-Kettering Cancer Center
  • Cassian Yee MD, MD Anderson Cancer Center

We look forward to seeing you at the 26th Annual Cancer Progress Conference on March17-18 at the Grand Hyatt New York in New York City!